Development and validation of an oxidative phosphorylation-related gene signature in lung adenocarcinoma

References

• 1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68(6), 394–424 (2018).
  MedlineGoogle Scholar
• 2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J. Clin. 70(1), 7–30 (2020).
  MedlineGoogle Scholar
• 3. Shi J, Hua X, Zhu B et al. Somatic genomics and clinical features of lung adenocarcinoma: a retrospective study. PLoS Med. 13(12), e1002162 (2016).
  MedlineGoogle Scholar
• 4. Liang Y, Wakelee HA. Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC). Transl. Lung Cancer Res. 2(5), 403–410 (2013).
  MedlineGoogle Scholar
• 5. Blandin Knight S, Crosbie PA, Balata H, Chudziak J, Hussell T, Dive C. Progress and prospects of early detection in lung cancer. Open Biol. 7(9), 170070 (2017).
  MedlineGoogle Scholar
• 6. Carter BW, Lichtenberger JP, Benveniste MK et al. Revisions to the TNM staging of lung cancer: rationale, significance, and clinical application. Radiographics 38(2), 374–391 (2018).
  MedlineGoogle Scholar
• 7. Sica V, Bravo-San Pedro JM, Stoll G, Kroemer G. Oxidative phosphorylation as a potential therapeutic target for cancer therapy. Int. J. Cancer 146(1), 10–17 (2020).
  Medline CASGoogle Scholar
• 8. Ashton TM, McKenna WG, Kunz-Schughart LA, Higgins GS. Oxidative phosphorylation as an emerging target in cancer therapy. Clin. Cancer Res. 24(11), 2482–2490 (2018).
  Medline CASGoogle Scholar
• 9. Kuntz EM, Baquero P, Michie AM et al. Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells. Nat. Med. 23(10), 1234–1240 (2017).
  Medline CASGoogle Scholar
• 10. Nayak AP, Kapur A, Barroilhet L, Patankar MS. Oxidative phosphorylation: a target for novel therapeutic strategies against ovarian cancer. Cancers 10(9), 337 (2018).
  MedlineGoogle Scholar
• 11. Rao S, Mondragón L, Pranjic B et al. AIF-regulated oxidative phosphorylation supports lung cancer development. Cell Res. 29(7), 579–591 (2019).
  Medline CASGoogle Scholar
• 12. Seijo LM, Peled N, Ajona D et al. Biomarkers in lung cancer screening: achievements, promises, and challenges. J. Thorac. Oncol. 14(3), 343–357 (2019).
  Medline CASGoogle Scholar
• 13. Kwa M, Makris A, Esteva FJ. Clinical utility of gene-expression signatures in early stage breast cancer. Nat. Rev. Clin. Oncol. 14(10), 595–610 (2017).
  Medline CASGoogle Scholar
• 14. Zhu X, Tian X, Yu C et al. A long non-coding RNA signature to improve prognosis prediction of gastric cancer. Mol. Cancer 15(1), 60 (2016).
  MedlineGoogle Scholar
• 15. Tomczak K, Czerwińska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp. Oncol. 19(1A), A68 (2015).
  Google Scholar
• 16. Colaprico A, Silva TC, Olsen C et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44(8), e71 (2016).
  MedlineGoogle Scholar
• 17. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30(1), 207–210 (2002).
  Medline CASGoogle Scholar
• 18. Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics 23(14), 1846–1847 (2007).
  MedlineGoogle Scholar
• 19. Brown GR, Hem V, Katz KS et al. Gene: a gene-centered information resource at NCBI. Nucleic Acids Res. 43(D1), D36–D42 (2015).
  Medline CASGoogle Scholar
• 20. Robinson JL, Kocabaş P, Wang H et al. An atlas of human metabolism. Sci. Signal. 13(624), eaaz1482 (2020).
  Medline CASGoogle Scholar
• 21. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1), 139–140 (2010).
  Medline CASGoogle Scholar
• 22. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B Methodol. 57(1), 289–300 (1995).
  Google Scholar
• 23. Wickham H. ggplot2: Elegant Graphics for Data Analysis (2nd Edition). Springer, Cham, Switzerland (2016).
  Google Scholar
• 24. Kolde R. Pheatmap: pretty heatmaps. R package version 61, 617 (2012).
  Google Scholar
• 25. Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5), 284–287 (2012).
  Medline CASGoogle Scholar
• 26. Walter W, Sánchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics 31(17), 2912–2914 (2015).
  Medline CASGoogle Scholar
• 27. Kuhn M. Building predictive models in R using the caret package. J. Stat. Softw. 28(5), 1–26 (2008).
  MedlineGoogle Scholar
• 28. Gordon M, Lumley T. forestplot: advanced forest plot using ‘grid’graphics. R package version 1(2), 70 (2017).
  Google Scholar
• 29. Friedman J, Hastie T, Tibshirani R. glmnet: lasso and elastic-net regularized generalized linear models. R package version 1(4), (2009). http://CRAN.R-project.org/package=glmnet
  Google Scholar
• 30. Heagerty P, Saha P. SurvivalROC: time-dependent ROC curve estimation from censored survival data. Biometrics 56(2), 337–344 (2000).
  Medline CASGoogle Scholar
• 31. Harrell FE Jr. rms: regression modeling strategies. R package version 5(2), (2016). http://CRAN.R-project.org/package=rms
  Google Scholar
• 32. Mayakonda A, Lin D-C, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28(11), 1747–1756 (2018).
  Medline CASGoogle Scholar
• 33. Robin X, Turck N, Hainard A et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12(1), 77 (2011).
  MedlineGoogle Scholar
• 34. Sun W, Hu S, Zu Y, Deng Y. KLF3 is a crucial regulator of metastasis by controlling STAT3 expression in lung cancer. Mol. Carcinog. 58(11), 1933–1945 (2019).
  Medline CASGoogle Scholar
• 35. Chen Y-J, Guo Y-N, Shi K et al. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data. Respir. Res. 20(1), 48 (2019).
  MedlineGoogle Scholar
• 36. Zhang J-X, Song W, Chen Z-H et al. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Lancet Oncol. 14(13), 1295–1306 (2013).
  Medline CASGoogle Scholar
• 37. Liu N, Chen N-Y, Cui R-X et al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol. 13(6), 633–641 (2012).
  Medline CASGoogle Scholar
• 38. Zhang L, Zhang Z, Yu Z. Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma. J. Transl. Med. 17(1), 423 (2019).
  Medline CASGoogle Scholar
• 39. Gu Y, Li P, Peng F et al. Autophagy-related prognostic signature for breast cancer. Mol. Carcinog. 55(3), 292–299 (2016).
  Medline CASGoogle Scholar
• 40. Shen S, Wang G, Zhang R et al. Development and validation of an immune gene-set based prognostic signature in ovarian cancer. EBioMedicine 40, 318–326 (2019).
  MedlineGoogle Scholar
• 41. Xu X-H, Bao Y, Wang X et al. Hypoxic-stabilized EPAS1 proteins transactivate DNMT1 and cause promoter hypermethylation and transcription inhibition of EPAS1 in non-small cell lung cancer. FASEB J. doi:10.1096/fj.201700715 (2018) (Epub ahead of print).
  Google Scholar
• 42. Yang S, Liu Y, Li M-Y et al. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer. Mol. Cancer 16(1), 124 (2017).
  MedlineGoogle Scholar
• 43. Nagano H, Hashimoto N, Nakayama A et al. p53-inducible DPYSL4 associates with mitochondrial supercomplexes and regulates energy metabolism in adipocytes and cancer cells. Proc. Natl Acad. Sci. U S A 115(33), 8370–8375 (2018).
  Medline CASGoogle Scholar
• 44. Warfel NA, El-Deiry WS. HIF-1 signaling in drug resistance to chemotherapy. Curr. Med. Chem. 21(26), 3021–3028 (2014).
  Medline CASGoogle Scholar
• 45. Von Morze C, Merritt ME. Cancer in the crosshairs: targeting cancer metabolism with hyperpolarized carbon-13 MRI technology. NMR Biomed. 32(10), e3937 (2019).
  MedlineGoogle Scholar
• 46. Fu H, Zhu Y, Wang Y et al. Identification and validation of stromal immunotype predict survival and benefit from adjuvant chemotherapy in patients with muscle-invasive bladder cancer. Clin. Cancer Res. 24(13), 3069–3078 (2018).
  Medline CASGoogle Scholar
• 47. Sohn I, Kim J, Jung S-H, Park C. Gradient lasso for Cox proportional hazards model. Bioinformatics 25(14), 1775–1781 (2009).
  Medline CASGoogle Scholar
• 48. Yan S, Wang Y, Chen M, Li G, Fan J. Deregulated SLC2A1 promotes tumor cell proliferation and metastasis in gastric cancer. Int. J. Mol. Sci. 16(7), 16144–16157 (2015).
  Medline CASGoogle Scholar
• 49. Jin L, Chun J, Pan C et al. Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis. Oncogene 36(27), 3797–3806 (2017).
  Medline CASGoogle Scholar
• 50. Pathria G, Scott DA, Feng Y et al. Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival. EMBO J. 37(20), e99735 (2018).
  MedlineGoogle Scholar
• 51. Amaral MD, Quaresma MC, Pankonien I. What role does CFTR play in development, differentiation, regeneration and cancer? Int. J. Mol. Sci. 21(9), 3133 (2020).
  Medline CASGoogle Scholar
• 52. Li Y, Sun Z, Wu Y et al. Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk. Lung Cancer 70(1), 14–21 (2010).
  MedlineGoogle Scholar
• 53. Kim S-K, Kim K, Ryu J-W et al. The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer. Int. J. Oncol. 54(1), 65–76 (2019).
  Medline CASGoogle Scholar
• 54. Qin Q, Xu Y, He T, Qin C, Xu J. Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res. 22(1), 90–106 (2012).
  Medline CASGoogle Scholar
• 55. Pan J, Fang S, Tian H et al. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling. Mol. Cancer 19(1), 9 (2020).
  Medline CASGoogle Scholar
• 56. Shi J, Li J, Yang S et al. LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-β pathway and IL-6/JAK2/STAT3 pathway. J. Cell. Physiol. 235(3), 2891–2900 (2020).
  Medline CASGoogle Scholar